-
Featured
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD
Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP, clinical manager of Emergency Medicine & Overnight Pharmacy Services at Massachusetts General Hospital, clarifies the risks and benefits of drugs like ibuprofen for use in patients with COVID-19.
-
Featured
Mass General First in New England to Enroll Patients in Remdesivir Clinical Trial for COVID-19
The hospital announces that the Infectious Disease Division has started enrolling patients in an international study of the antiviral drug, Remdesivir, which aims to treat those with the novel coronavirus (COVID-19).
-
Medical Grand Rounds: Pathogenesis and Management of Respiratory Failure in COVID-19: What We Know So Far
On March 26, 2020, the Department of Medicine held its third virtual Grand Rounds presentation related to COVID-19. Benjamin Medoff, MD, chief of Pulmonary and Critical Care at Massachusetts General Hospital, along with other members of the Greater Boston medical community, presented on respiratory failure in COVID-19, including management, treatment in clinical trials and the need for biomarkers.
-
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Developing New Assays for Novel COVID-19: Q&A with David Louis, MD
David Louis, MD, pathologist-in-chief at Massachusetts General Hospital, explains how COVID-19 assays are being rapidly developed and what Mass General is doing to alleviate the scarcity of tests.
-
Hypertension and CVD Are Among Risk Factors for Severe COVID-19
Many patients in a cardiology practice are at risk of developing severe COVID-19 if they become infected with SARS-CoV-2, the new coronavirus.
COVID-19 contributors
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Mass General First in New England to Enroll Patients in Remdesivir Clinical Trial for COVID-19 -
Katrina A. Armstrong, MD
Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: Pathogenesis and Management of Respiratory Failure in COVID-19: What We Know So Far
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity
